Health Robotics Expands i.v.STATION(R) Footprint in North America With Children's Hospital of Los Angeles

BOZEN, SUD-TIROL, Italy, January 10, 2011 - Health Robotics today announced its first 2011 contract for the
installation of 2 i.v.STATION robots at Children's Hospital of Los Angeles,
marking the third California hospital, after Cottage Health System and
Memorial Care, to purchase 2 i.v.STATIONs each. The installation of the 2
i.v.STATIONs is scheduled to occur during 1Q2011 initially focusing on
antibiotics and controlled substances, and in conjunction with Health
Robotics' i.v.SOFT Assist Workflow Engine for Chemotherapy. Finally, this new
agreement also represents the third i.v.STATION for Pediatrics sold in the
United States of America, after Miller Children's Hospital in Long Beach.

"The worldwide recognition of Children's Hospital of Los Angeles'
outstanding quality and experience carries a great deal of importance for
Health Robotics and its continued global dominance of the IV Automation
Sector. I'm particularly pleased that Children's Hospital of Los Angeles
compared and verified i.v.STATION's superior R.O.I., throughput, and
high-availability features after site visits to Cottage Health System for
i.v.STATION, and a competitor's solution [RIVA] installed at another nearby
Southern California pediatric institution. Everyone at Health Robotics is
very proud of our American partners' [McKesson and HRCI] continued support,
thus enabling such a great American kick-off for the company in 2011" stated
Gaspar DeViedma, Health Robotics' Executive Vice President.

i.v.STATION's $275,000 price, combined with its plug-and-play
installation, flexibility for bags' and syringes' brands and sizes, ISO-5
controlled environment, and unprecedented robotic throughput, has already
revolutionized Non-Hazardous Sterile Compounding in North America. Multiple
hospital studies have proven an i.v.STATION's 3-to-1 cost advantage over
Pre-Mix/Frozen solutions by Baxter, B. Braun, and Hospira, and also
consistently revealed a 6-to-1 cost advantage over outsourced custom IV
manufacturing offered by Ameridose, CAPS, and PharMEDium in multiple North
American local markets. Furthermore, i.v.STATION/RIVA comparison studies have
shown public evidence that i.v.STATION is 4 times faster than RIVA. When
factoring in RIVA's $1M+ higher price, i.v.STATION is 20 times less expensive
than RIVA on a per-dose basis.

About Children's Hospital Los Angeles:

Founded in 1901, Children's Hospital Los Angeles is one of the nation's
leading children's hospitals and is acknowledged worldwide for its leadership
in pediatric and adolescent health. Children's Hospital Los Angeles is one of
only seven children's hospitals in the nation - and the only children's
hospital on the West Coast - ranked for two consecutive years in all 10
pediatric specialties in the U.S. News & World Report rankings and named to
the magazine's "Honor Roll" of children's hospitals. The Saban Research
Institute at Children's Hospital Los Angeles is among the largest and most
productive pediatric research facilities in the United States, with 100
investigators at work on 186 laboratory studies, clinical trials and
community-based research and health services. The Saban Research Institute is
ranked eighth in National Institutes of Health funding among children's
hospitals in the United States. Children's Hospital Los Angeles is a premier
teaching hospital and has been affiliated with the Keck School of Medicine of
the University of Southern California since 1932.

About Health Robotics:

Health Robotics is the undisputed global leading supplier of
life-critical intra-venous medication robots, providing healthcare facilities
in 5 continents with robotics technology and software automation solutions
deployed utilizing virtual high-availability technology. Its world-leading
solutions CytoCare(R) [hazardous IVs], i.v.STATION(R) [non-hazardous IVs],
i.v.SOFT(R) [manual compounding software], MEDarchiver(R) [clinical information
system], and TPNstation(TM) [totally-automated parenteral nutrition] have and
will greatly contribute to ease hospitals' growing pressures to improve
patient safety, increase throughput and contain costs. Through the effective
and efficient production of sterile, accurate, tamper-evident and
ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate
life-threatening drug-exchange errors, decrease other medical errors and
sterility risks, work more efficiently, reduce waste and controlled
substances' diversion, and diminish the gap between rising patient
volume/acuity and scarce medical, nursing, and pharmacy staff. For more
company information, please visit www.health-robotics.com/

    For additional information, please contact:

    Claudia Flaim, Marketing Coordinator
    flaim@health-robotics.com
    Phone: +39-0471-200-372

For additional information, please contact: Claudia Flaim, Marketing Coordinator, flaim at health-robotics.com , Phone: +39-0471-200-372.